日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis

呋喹替尼治疗难治性转移性结直肠癌的疗效和安全性：系统评价和荟萃分析

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-2025-385
Udaikumar, Jahnavi; Ingawale, Sushrut; Nimmagadda, Rithish; Kuppili, Satwik; Lella, Vindhya Vasini; Suvvari, Tarun Kumar; Cheloff, Abraham; Bellamkonda, Amulya; Giri, Suprabhat; Oberstein, Paul; Shaukat, Aasma
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Current Perspectives on Colorectal Cancer Screening and Surveillance in the Geriatric Population

当前对老年人群结直肠癌筛查和监测的看法

期刊:Current Gastroenterology Reports
影响因子:
doi:10.1007/s11894-025-00985-5
Udaikumar, Jahnavi; Nimmagadda, Rithish; Ingawale, Sushrut; Lella, Vindhya Vasini; Vijayakumar, Keerthika; Faye, Adam S; Shaukat, Aasma
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

PROTACs in the Management of Prostate Cancer

PROTACs 在前列腺癌管理中的应用

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules28093698
Yedla, Poornachandra; Babalghith, Ahmed O; Andra, Vindhya Vasini; Syed, Riyaz
肿瘤
前列腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

纳米脂质体多西他赛混悬液（NDLS）与传统多西他赛作为原发性可手术乳腺癌新辅助和辅助治疗的疗效和安全性比较

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S400824
Badiginchala, Revathi; Dattatreya, Palanki Satya; Suresh, Attili Venkata Satya; Nirni, Sharanabasappa Somanath; Andra, Vindhya Vasini; Bunger, Deepak; Chaturvedi, Alok
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏